In conclusion, molecules such as RUNX2, CBX3, and MYC interact with YBX1 to promote tumor progression in various malignant tumors, including bone cancer, pancreatic cancer, and rhabdomyosarcoma, among others. The gene discussed is CBX3; the disease is familial pancreatic carcinoma.